Drug profile · INN
emtricitabine + tenofovir alafenamide
DESCOVY
emtricitabine + tenofovir alafenamide (DESCOVY) is an FDA-listed pharmaceutical active ingredient. Associated with Gilead Sciences Pty Limited.
TGA: approved
Patents linked 0
Pipeline programs 10
News articles 0
Drug details — emtricitabine + tenofovir alafenamide
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 10
- Data quality
- 0.81
Quick answer
emtricitabine + tenofovir alafenamide (DESCOVY) is an FDA-listed pharmaceutical active ingredient. Associated with Gilead Sciences Pty Limited.
Key facts
Approval history
| Authority | Status | Date |
|---|---|---|
| TGA | approved | — |
Pipeline programs
Frequently asked questions
What is emtricitabine + tenofovir alafenamide?
emtricitabine + tenofovir alafenamide (DESCOVY) is an FDA-listed pharmaceutical active ingredient. Associated with Gilead Sciences Pty Limited.
What is the brand name for emtricitabine + tenofovir alafenamide?
DESCOVY is a marketed brand name for emtricitabine + tenofovir alafenamide. Check FDA Drugs@FDA for the current US label holder and prescribing information.